How to Buy gls Shares on Fincept?
You can buy Alivus Life Sciences Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Alivus Life Sciences Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Gls, including updates on board meetings and corporate actions.
Alivus Life Sciences Limited - https://www.glenmarklifesciences.com
Glenmark Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, atovaquone, solifenacin, mirabegron, sitagliptin, zonisamide, adapalene, and rosuvastatin. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company's APIs are used in various therapeutic segments, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was incorporated in 2011 and is based in Mumbai, India. Glenmark Life Sciences Limited is a subsidiary of Nirma Limited.
Alivus Life Sciences Limited Share Price Today
1,160.00
OPEN
1,186.00
HIGH
1,147.05
LOW
1,156.50
CLOSE
104 K
VOLUME
12,266 Cr
Market Cap
155674
Average Volume
Healthcare
Sector
NSI
Exchange
Alivus Life Sciences Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: GLS Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Glenmark Life Sciences Limited |
GLS |
INE03Q201024 |
Interim Dividend - Rs 22.50 Per Share |
17 Oct 2023 |
2 |
N/A |
Glenmark Life Sciences Limited |
GLS |
INE03Q201024 |
Annual General Meeting |
22 Sep 2023 |
2 |
N/A |
Glenmark Life Sciences Limited |
GLS |
INE03Q201024 |
Interim Dividend - Rs 21 Per Share |
24 Mar 2023 |
2 |
N/A |
Glenmark Life Sciences Limited |
GLS |
INE03Q201024 |
Dividend - Rs 10.5 Per Share |
15 Sep 2022 |
2 |
N/A |
Glenmark Life Sciences Limited |
GLS |
INE03Q201024 |
Interim Dividend - Rs 10.50 Per Share |
22 Nov 2021 |
2 |
N/A |
NSE: GLS Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
GLS |
17 Dec 2024, 18:33:22 |
Name Change |
N/A |
GLS |
27 Nov 2024, 15:44:55 |
Shareholders meeting |
N/A |
GLS |
25 Nov 2024, 16:42:46 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
GLS |
22 Nov 2024, 16:50:02 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
GLS |
31 Oct 2024, 22:41:50 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
NSE: GLS Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Glenmark Life Sciences Limited |
GLS |
17 Oct 2024, 11:56:00 |
17 Oct 2024, 11:56:00 |
|
Glenmark Life Sciences Limited |
GLS |
07 Nov 2024, 18:13:00 |
07 Nov 2024, 18:13:00 |
|
Glenmark Life Sciences Limited |
GLS |
18 Jul 2024, 14:16:00 |
18 Jul 2024, 14:16:00 |
|
Glenmark Life Sciences Limited |
GLS |
19 Apr 2024, 14:34:00 |
19 Apr 2024, 15:00:00 |
|
Glenmark Life Sciences Limited |
GLS |
12 Jan 2024, 15:45:00 |
12 Jan 2024, 16:15:00 |
NSE: GLS Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson Related To Promoters,Non-Executive Director |
29 Jul 1973 |
06 Mar 2024 |
00145149 |
Hiren Karsanbhai Patel |
- |
Executive Director-CEO-MD |
25 Dec 1965 |
13 Aug 2019 |
01965174 |
Yasir Y Rawjee |
- |
Executive Director |
03 Sep 1963 |
21 Oct 2022 |
03635487 |
Vinod Naik |
- |
Independent Director |
02 Dec 1955 |
06 Mar 2024 |
00145086 |
Kaushikbhai N Patel |
- |
Independent Director |
11 Sep 1952 |
06 Mar 2024 |
00376570 |
Vijay Ratilal Shah |
- |
NSE: GLS Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 24-Oct-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended September 2024 . |
GLS |
N/A |
INE03Q201024 |
Glenmark Life Sciences Limited |
17 Oct 2024, 15:39:49 |
Financial Results |
GLS |
N/A |
INE03Q201024 |
Glenmark Life Sciences Limited |
18 Jul 2024, 16:50:17 |
Financial Results |
GLS |
N/A |
INE03Q201024 |
Glenmark Life Sciences Limited |
18 Apr 2024, 16:52:02 |
Financial Results |
GLS |
N/A |
INE03Q201024 |
Glenmark Life Sciences Limited |
15 Jan 2024, 16:06:02 |
Financial Results |
GLS |
N/A |
INE03Q201024 |
Glenmark Life Sciences Limited |
13 Oct 2023, 17:37:02 |
NSE: GLS Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
GLS |
- |
INE03Q201024 |
Glenmark Life Sciences Limited |
17 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
GLS |
- |
INE03Q201024 |
Glenmark Life Sciences Limited |
18 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results |
GLS |
- |
INE03Q201024 |
Glenmark Life Sciences Limited |
18 Apr 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 |
Financial Results |
GLS |
- |
INE03Q201024 |
Glenmark Life Sciences Limited |
15 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results |
GLS |
- |
INE03Q201024 |
Glenmark Life Sciences Limited |
13 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 |
NSE: GLS Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Investmentin Financial Assets | Available For Sale Securities | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 122,528,672.00 | 122,528,672.00 | 159,770,000.00 | 25,212,100,000.00 | 25,384,800,000.00 | 16,323,240,000.00 | 25,212,100,000.00 | 159,770,000.00 | 25,384,800,000.00 | 25,384,800,000.00 | 25,384,800,000.00 | 25,384,800,000.00 | 25,139,740,000.00 | 0.00 | 0.00 | 245,060,000.00 | 245,060,000.00 | 5,463,790,000.00 | 826,450,000.00 | 0.00 | 516,730,000.00 | 133,800,000.00 | 133,800,000.00 | 175,920,000.00 | 4,637,340,000.00 | 108,080,000.00 | 0.00 | 25,970,000.00 | 25,970,000.00 | 0.00 | 0.00 | 138,450,000.00 | 3,981,650,000.00 | 0.00 | 0.00 | 0.00 | 3,981,650,000.00 | 30,848,590,000.00 | 9,888,010,000.00 | 77,170,000.00 | 0.00 | 111,210,000.00 | 111,210,000.00 | 172,700,000.00 | 172,700,000.00 | 9,451,240,000.00 | 0.00 | 9,451,240,000.00 | 1,413,820,000.00 | 8,037,420,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20,960,580,000.00 | 1,015,260,000.00 | 0.00 | 0.00 | 6,892,030,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,751,270,000.00 | 0.00 | 0.00 | 5,302,020,000.00 | 840,850,000.00 | 4,461,170,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 122,527,172.00 | 122,527,172.00 | 171,480,000.00 | 23,174,700,000.00 | 23,323,220,000.00 | 14,772,260,000.00 | 23,174,700,000.00 | 171,480,000.00 | 23,323,220,000.00 | 23,323,220,000.00 | 23,323,220,000.00 | 23,323,220,000.00 | 110,580,000.00 | 12,918,030,000.00 | 10,049,560,000.00 | 245,050,000.00 | 245,050,000.00 | 5,180,900,000.00 | 793,170,000.00 | 157,710,000.00 | 487,850,000.00 | 147,610,000.00 | 147,610,000.00 | 157,710,000.00 | 4,387,730,000.00 | 154,230,000.00 | 0.00 | 23,870,000.00 | 23,870,000.00 | 0.00 | 120,340,000.00 | 120,340,000.00 | 4,190,940,000.00 | 502,530,000.00 | 1,800,000.00 | 0.00 | 3,686,610,000.00 | 28,504,120,000.00 | 9,344,130,000.00 | 10,000.00 | 147,020,000.00 | 770,000.00 | 770,000.00 | 148,520,000.00 | 148,520,000.00 | 9,047,810,000.00 | -1,993,600,000.00 | 11,041,410,000.00 | 1,097,690,000.00 | 7,950,120,000.00 | 6,273,290,000.00 | 3,396,050,000.00 | 274,380,000.00 | 0.00 | 19,159,990,000.00 | 5,180,000.00 | 1,800,000.00 | 914,960,000.00 | 6,665,910,000.00 | 696,830,000.00 | 4,082,560,000.00 | 1,886,520,000.00 | 903,680,000.00 | 0.00 | 7,654,320,000.00 | -3,070,000.00 | 7,657,390,000.00 | 3,014,140,000.00 | 905,480,000.00 | 3,014,140,000.00 | 2,695,960,000.00 | 318,180,000.00 |
| 2024-03-31T00:00:00 | annual | 122,527,172.00 | 122,527,172.00 | 171,480,000.00 | 23,174,700,000.00 | 23,323,220,000.00 | 14,772,260,000.00 | 23,174,700,000.00 | 171,480,000.00 | 23,323,220,000.00 | 23,323,220,000.00 | 23,323,220,000.00 | 23,323,220,000.00 | 110,580,000.00 | 12,918,030,000.00 | 10,049,560,000.00 | 245,050,000.00 | 245,050,000.00 | 5,180,900,000.00 | 793,170,000.00 | 157,710,000.00 | 487,850,000.00 | 147,610,000.00 | 147,610,000.00 | 157,710,000.00 | 4,387,730,000.00 | 154,230,000.00 | 0.00 | 23,870,000.00 | 23,870,000.00 | 0.00 | 120,340,000.00 | 120,340,000.00 | 4,190,940,000.00 | 502,530,000.00 | 1,800,000.00 | 0.00 | 3,686,610,000.00 | 28,504,120,000.00 | 9,344,130,000.00 | 10,000.00 | 147,020,000.00 | 770,000.00 | 770,000.00 | 148,520,000.00 | 148,520,000.00 | 9,047,810,000.00 | -1,993,600,000.00 | 11,041,410,000.00 | 1,097,690,000.00 | 7,950,120,000.00 | 6,273,290,000.00 | 3,396,050,000.00 | 274,380,000.00 | 0.00 | 19,159,990,000.00 | 5,180,000.00 | 1,800,000.00 | 914,960,000.00 | 6,665,910,000.00 | 696,830,000.00 | 4,082,560,000.00 | 1,886,520,000.00 | 903,680,000.00 | 0.00 | 7,654,320,000.00 | -3,070,000.00 | 7,657,390,000.00 | 3,014,140,000.00 | 905,480,000.00 | 3,014,140,000.00 | 2,695,960,000.00 | 318,180,000.00 |
| 2023-09-30T00:00:00 | quarterly | 122,527,172.00 | 122,527,172.00 | 182,840,000.00 | 23,744,970,000.00 | 23,917,370,000.00 | 15,776,790,000.00 | 23,744,970,000.00 | 182,840,000.00 | 23,917,370,000.00 | 23,917,370,000.00 | 23,917,370,000.00 | 23,917,370,000.00 | 23,672,320,000.00 | 0.00 | 0.00 | 245,050,000.00 | 245,050,000.00 | 5,612,400,000.00 | 622,370,000.00 | 0.00 | 462,440,000.00 | 159,930,000.00 | 159,930,000.00 | 0.00 | 4,990,030,000.00 | 92,860,000.00 | 0.00 | 22,910,000.00 | 22,910,000.00 | 0.00 | 0.00 | 211,780,000.00 | 4,084,970,000.00 | 0.00 | 0.00 | 232,900,000.00 | 3,852,070,000.00 | 29,529,770,000.00 | 8,762,950,000.00 | 68,210,000.00 | 0.00 | 84,360,000.00 | 84,360,000.00 | 172,400,000.00 | 172,400,000.00 | 8,437,980,000.00 | 0.00 | 8,437,980,000.00 | 780,660,000.00 | 7,657,320,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20,766,820,000.00 | 848,600,000.00 | 0.00 | 0.00 | 6,695,120,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8,074,640,000.00 | 0.00 | 0.00 | 5,148,460,000.00 | 718,990,000.00 | 4,429,470,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 122,527,172.00 | 122,527,172.00 | 193,570,000.00 | 21,202,060,000.00 | 21,382,070,000.00 | 13,537,950,000.00 | 21,202,060,000.00 | 193,570,000.00 | 21,382,070,000.00 | 21,382,070,000.00 | 21,382,070,000.00 | 21,382,070,000.00 | 66,830,000.00 | 11,020,630,000.00 | 10,049,560,000.00 | 245,050,000.00 | 245,050,000.00 | 5,639,400,000.00 | 673,960,000.00 | 78,700,000.00 | 424,340,000.00 | 170,920,000.00 | 170,920,000.00 | 0.00 | 4,965,440,000.00 | 296,760,000.00 | 70,780,000.00 | 22,650,000.00 | 22,650,000.00 | 0.00 | 76,680,000.00 | 155,380,000.00 | 4,775,900,000.00 | 502,680,000.00 | 950,000.00 | 70,780,000.00 | 4,272,270,000.00 | 27,021,470,000.00 | 8,518,080,000.00 | 12,720,000.00 | 82,140,000.00 | 770,000.00 | 770,000.00 | 180,010,000.00 | 180,010,000.00 | 8,255,160,000.00 | -1,516,220,000.00 | 9,771,380,000.00 | 506,260,000.00 | 7,748,900,000.00 | 5,742,590,000.00 | 3,248,150,000.00 | 274,380,000.00 | 0.00 | 18,503,390,000.00 | 6,430,000.00 | 255,740,000.00 | 584,220,000.00 | 6,041,710,000.00 | 503,840,000.00 | 3,709,070,000.00 | 1,828,800,000.00 | 709,400,000.00 | 276,000,000.00 | 8,067,660,000.00 | 0.00 | 8,067,660,000.00 | 2,838,230,000.00 | 440,120,000.00 | 2,838,230,000.00 | 2,280,600,000.00 | 557,630,000.00 |
| 2023-03-31T00:00:00 | annual | 122,527,172.00 | 122,527,172.00 | 193,570,000.00 | 21,202,060,000.00 | 21,382,070,000.00 | 13,537,950,000.00 | 21,202,060,000.00 | 193,570,000.00 | 21,382,070,000.00 | 21,382,070,000.00 | 21,382,070,000.00 | 21,382,070,000.00 | 66,830,000.00 | 11,020,630,000.00 | 10,049,560,000.00 | 245,050,000.00 | 245,050,000.00 | 5,639,400,000.00 | 673,960,000.00 | 78,700,000.00 | 424,340,000.00 | 170,920,000.00 | 170,920,000.00 | 0.00 | 4,965,440,000.00 | 296,760,000.00 | 70,780,000.00 | 22,650,000.00 | 22,650,000.00 | 0.00 | 76,680,000.00 | 155,380,000.00 | 4,775,900,000.00 | 502,680,000.00 | 950,000.00 | 70,780,000.00 | 4,272,270,000.00 | 27,021,470,000.00 | 8,518,080,000.00 | 12,720,000.00 | 82,140,000.00 | 770,000.00 | 770,000.00 | 180,010,000.00 | 180,010,000.00 | 8,255,160,000.00 | -1,516,220,000.00 | 9,771,380,000.00 | 506,260,000.00 | 7,748,900,000.00 | 5,742,590,000.00 | 3,248,150,000.00 | 274,380,000.00 | 0.00 | 18,503,390,000.00 | 6,430,000.00 | 255,740,000.00 | 584,220,000.00 | 6,041,710,000.00 | 503,840,000.00 | 3,709,070,000.00 | 1,828,800,000.00 | 709,400,000.00 | 276,000,000.00 | 8,067,660,000.00 | 0.00 | 8,067,660,000.00 | 2,838,230,000.00 | 440,120,000.00 | 2,838,230,000.00 | 2,280,600,000.00 | 557,630,000.00 |
| 2022-03-31T00:00:00 | annual | 122,527,172.00 | 122,527,172.00 | 28,840,000.00 | 20,439,320,000.00 | 20,543,120,000.00 | 13,805,880,000.00 | 20,439,320,000.00 | 28,840,000.00 | 20,543,120,000.00 | 20,543,120,000.00 | 20,543,120,000.00 | 20,543,120,000.00 | 34,980,000.00 | 10,213,530,000.00 | 10,049,560,000.00 | 245,050,000.00 | 245,050,000.00 | 4,166,950,000.00 | 326,990,000.00 | 0.00 | 314,950,000.00 | 12,040,000.00 | 12,040,000.00 | 0.00 | 3,839,960,000.00 | 34,010,000.00 | 0.00 | 16,800,000.00 | 16,800,000.00 | 0.00 | 0.00 | 144,350,000.00 | 3,391,320,000.00 | 27,180,000.00 | 70,000.00 | 120,030,000.00 | 3,244,040,000.00 | 24,710,070,000.00 | 7,064,230,000.00 | 140,700,000.00 | 55,600,000.00 | 770,000.00 | 770,000.00 | 103,800,000.00 | 103,800,000.00 | 6,904,060,000.00 | -1,129,880,000.00 | 8,033,940,000.00 | 1,057,580,000.00 | 5,846,480,000.00 | 4,426,400,000.00 | 2,275,580,000.00 | 274,380,000.00 | 0.00 | 17,645,840,000.00 | 567,840,000.00 | 70,000.00 | 158,210,000.00 | 5,162,440,000.00 | 264,380,000.00 | 3,104,540,000.00 | 1,793,520,000.00 | 225,590,000.00 | 191,630,000.00 | 6,734,870,000.00 | 0.00 | 0.00 | 5,173,030,000.00 | 51,460,000.00 | 5,121,570,000.00 | 4,900,000,000.00 | 221,570,000.00 |
| 2021-03-31T00:00:00 | annual | 122,527,172.00 | 122,527,172.00 | 0.00 | 7,448,360,000.00 | 7,527,470,000.00 | 1,776,010,000.00 | 7,448,360,000.00 | 0.00 | 7,527,470,000.00 | 7,527,470,000.00 | 7,527,470,000.00 | 7,527,470,000.00 | 7,507,870,000.00 | 7,507,870,000.00 | 0.00 | 19,600,000.00 | 19,600,000.00 | 12,443,280,000.00 | 228,880,000.00 | 0.00 | 228,880,000.00 | 0.00 | 0.00 | 0.00 | 12,214,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 199,020,000.00 | 199,020,000.00 | 11,738,170,000.00 | 9,375,290,000.00 | 0.00 | 136,930,000.00 | 2,225,950,000.00 | 19,970,750,000.00 | 5,980,340,000.00 | 0.00 | 85,460,000.00 | 770,000.00 | 770,000.00 | 79,110,000.00 | 79,110,000.00 | 5,803,490,000.00 | -772,760,000.00 | 6,576,250,000.00 | 154,610,000.00 | 0.00 | 4,129,080,000.00 | 2,119,220,000.00 | 173,340,000.00 | 0.00 | 13,990,410,000.00 | 0.00 | 0.00 | 190,200,000.00 | 5,134,210,000.00 | 362,270,000.00 | 3,418,940,000.00 | 1,353,000,000.00 | 627,550,000.00 | 445,850,000.00 | 6,195,000,000.00 | 0.00 | 0.00 | 1,397,600,000.00 | 241,640,000.00 | 1,155,960,000.00 | 0.00 | 1,155,960,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 210,000.00 | 139,830,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 126,070,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: GLS Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Net Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 2,845,460,000.00 | 0.00 | -1,289,690,000.00 | 3,014,140,000.00 | 2,838,230,000.00 | 175,910,000.00 | -2,794,410,000.00 | -220,000.00 | -15,240,000.00 | -2,756,860,000.00 | -2,756,860,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,164,830,000.00 | 0.00 | 120,210,000.00 | 0.00 | 0.00 | 0.00 | -1,285,040,000.00 | 4,650,000.00 | -1,289,690,000.00 | 4,135,150,000.00 | -1,629,630,000.00 | -1,340,800,000.00 | -551,930,000.00 | -341,210,000.00 | -826,260,000.00 | -173,330,000.00 | -104,750,000.00 | 43,750,000.00 | 205,130,000.00 | 534,520,000.00 | 36,740,000.00 | 497,780,000.00 | 78,000,000.00 | -2,670,000.00 | 7,040,000.00 | 6,312,900,000.00 |
| 2023-03-31T00:00:00 | annual | 1,432,080,000.00 | 0.00 | -1,627,980,000.00 | 2,838,230,000.00 | 5,121,570,000.00 | -2,283,340,000.00 | -3,875,930,000.00 | -320,000.00 | -5,150,000.00 | -3,859,180,000.00 | -3,859,180,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,467,470,000.00 | 0.00 | 157,660,000.00 | 1,110,000.00 | 1,110,000.00 | 0.00 | -1,626,240,000.00 | 1,740,000.00 | -1,627,980,000.00 | 3,060,060,000.00 | -1,535,650,000.00 | -2,136,600,000.00 | -735,630,000.00 | 907,790,000.00 | -972,270,000.00 | -2,072,120,000.00 | -152,190,000.00 | 31,850,000.00 | 93,000,000.00 | 420,940,000.00 | 14,460,000.00 | 406,480,000.00 | 34,430,000.00 | 8,900,000.00 | 5,580,000.00 | 6,286,090,000.00 |
| 2022-03-31T00:00:00 | annual | 4,654,130,000.00 | 10,118,540,000.00 | -1,321,720,000.00 | 5,121,570,000.00 | 1,155,960,000.00 | 3,965,610,000.00 | -787,960,000.00 | -9,328,670,000.00 | -277,640,000.00 | -1,286,540,000.00 | -1,286,540,000.00 | 10,118,540,000.00 | 10,118,540,000.00 | -9,328,670,000.00 | 0.00 | -9,328,670,000.00 | -1,222,280,000.00 | 0.00 | 66,700,000.00 | 28,050,000.00 | 28,050,000.00 | 0.00 | -1,317,030,000.00 | 4,690,000.00 | -1,321,720,000.00 | 5,975,850,000.00 | -1,381,660,000.00 | 998,400,000.00 | 881,290,000.00 | 737,490,000.00 | -28,230,000.00 | 289,140,000.00 | 211,810,000.00 | 34,980,000.00 | 0.00 | 378,770,000.00 | 0.00 | 378,770,000.00 | 31,790,000.00 | -3,110,000.00 | 7,430,000.00 | 5,649,250,000.00 |
| 2021-03-31T00:00:00 | annual | 3,201,200,000.00 | 0.00 | -679,930,000.00 | 1,155,960,000.00 | 99,980,000.00 | 1,055,980,000.00 | -2,137,810,000.00 | -2,137,810,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2,137,810,000.00 | -2,137,810,000.00 | -2,137,810,000.00 | -687,340,000.00 | -28,050,000.00 | 4,300,000.00 | -28,050,000.00 | 0.00 | -28,050,000.00 | -663,590,000.00 | 16,340,000.00 | -679,930,000.00 | 3,881,130,000.00 | -1,085,640,000.00 | -1,075,770,000.00 | -491,210,000.00 | 340,890,000.00 | -1,006,460,000.00 | -410,200,000.00 | 870,400,000.00 | 0.00 | 0.00 | 333,940,000.00 | 0.00 | 333,940,000.00 | 34,980,000.00 | 87,940,000.00 | 5,840,000.00 | 4,709,440,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,365,520,000.00 | -1,365,520,000.00 | -1,365,520,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: GLS Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Net Non Operating Interest Income Expense | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -0.18 | 0.00 | 686.99 | -0.70 | -0.70 | 470.89 | 53.45 | 1,020.70 | 686.29 | 632.84 | 10.48 | 1.55 | 12.02 | 471.41 | 470.89 | 1,562.64 | 0.38 | 12.27 | 12.25 | 0.00 | 0.00 | 470.89 | 470.89 | 0.00 | 470.89 | 470.89 | 470.89 | 160.40 | 631.29 | 0.02 | -0.70 | 0.70 | 10.48 | 1.55 | 12.02 | 622.14 | 541.93 | 215.16 | 53.45 | 3.67 | 49.78 | 0.00 | 39.56 | 24.04 | 15.52 | 0.38 | 1,164.07 | 1,020.70 | 2,184.77 | 2,184.77 |
| 2023-03-31T00:00:00 | annual | -0.14 | 0.00 | 671.81 | -0.56 | -0.56 | 466.96 | 42.09 | 1,031.35 | 671.25 | 629.16 | 15.22 | 0.55 | 15.77 | 467.38 | 466.96 | 1,447.08 | 0.42 | 12.25 | 12.25 | 0.00 | 0.00 | 466.96 | 466.96 | 0.00 | 466.96 | 466.96 | 466.96 | 161.65 | 628.61 | 0.17 | -0.56 | 0.56 | 15.22 | 0.55 | 15.77 | 600.76 | 415.74 | 215.47 | 42.09 | 1.45 | 40.65 | 0.00 | 33.77 | 24.62 | 9.15 | 0.42 | 1,016.50 | 1,031.35 | 2,047.84 | 2,047.84 |
| 2022-03-31T00:00:00 | annual | -0.19 | 0.00 | 631.51 | -0.74 | -0.74 | 418.72 | 37.88 | 1,057.70 | 630.76 | 592.89 | -21.18 | 27.96 | 6.78 | 419.27 | 418.72 | 1,508.52 | 0.22 | 11.75 | 11.75 | 0.00 | 0.00 | 418.72 | 418.72 | 0.00 | 418.72 | 418.72 | 418.72 | 146.20 | 564.93 | 0.32 | -0.74 | 0.74 | -21.18 | 27.96 | 6.78 | 578.93 | 450.82 | 187.52 | 37.88 | 0.00 | 37.88 | 0.00 | 30.98 | 22.83 | 8.15 | 0.22 | 1,029.75 | 1,057.70 | 2,087.45 | 2,087.45 |
| 2021-03-31T00:00:00 | annual | -0.15 | 0.00 | 592.47 | -0.58 | -0.58 | 351.58 | 33.39 | 915.69 | 591.89 | 558.49 | -87.12 | 87.55 | 0.43 | 352.02 | 351.58 | 1,299.67 | 0.16 | 12.25 | 12.25 | 0.00 | 0.00 | 351.58 | 351.58 | 0.00 | 351.58 | 351.58 | 351.58 | 119.36 | 470.94 | 0.38 | -0.58 | 0.58 | -87.12 | 87.55 | 0.43 | 561.72 | 383.99 | 143.14 | 33.39 | 0.00 | 33.39 | 0.29 | 41.28 | 33.79 | 7.50 | 0.16 | 945.71 | 915.69 | 1,861.40 | 1,861.40 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
34.45
P/E
29.056602
P/B
4.8311043
Dividend Yield
3.71%
Market Cap
12,265.55 Cr.
Face Value
207.199
Book Value
207.199
ROE
19.21%
EBITDA Growth
602.72 Cr.
Debt/Equity
0.629
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of gls?
The market capitalization of Alivus Life Sciences Limited is ₹12,266 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Alivus Life Sciences Limited?
The PE and PB ratios of Alivus Life Sciences Limited are Not Available and 4.8311043 respectively as of 05 Feb 2025.
What is the 52 Week High of Alivus Life Sciences Limited?
The 52-week high of Alivus Life Sciences Limited is ₹1335.1 as of 05 Feb 2025.
What is the 52 Week Low of Alivus Life Sciences Limited?
The 52-week low of Alivus Life Sciences Limited is ₹645.35 as of 05 Feb 2025.
What are the earnings per share (EPS) for Alivus Life Sciences Limited?
The Earnings Per Share (EPS) of Alivus Life Sciences Limited is ₹34.45 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Alivus Life Sciences Limited?
The Return on Equity (ROE) of Alivus Life Sciences Limited is 19.21% as per the most recent financial year data. Explore more on Fincept.